Once-daily administration of trospium chloride extended release provides 24-hr coverage of nocturnal and diurnal symptoms of overactive bladder: an integrated analysis of two phase III trials.
about
A prospective, comparative study of the occurrence and severity of constipation with darifenacin and trospium in overactive bladder.Pharmacotherapy of overactive bladder in adults: a review of efficacy, tolerability, and quality of life.The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapy.[Trospium chloride once daily for overactive bladder syndrome: results of a multicenter observational study].
P2860
Once-daily administration of trospium chloride extended release provides 24-hr coverage of nocturnal and diurnal symptoms of overactive bladder: an integrated analysis of two phase III trials.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Once-daily administration of t ...... lysis of two phase III trials.
@en
Once-daily administration of t ...... lysis of two phase III trials.
@nl
type
label
Once-daily administration of t ...... lysis of two phase III trials.
@en
Once-daily administration of t ...... lysis of two phase III trials.
@nl
prefLabel
Once-daily administration of t ...... lysis of two phase III trials.
@en
Once-daily administration of t ...... lysis of two phase III trials.
@nl
P2093
P2860
P356
P1476
Once-daily administration of t ...... lysis of two phase III trials.
@en
P2093
David A Ginsberg
Michael G Oefelein
Pamela I Ellsworth
P2860
P304
P356
10.1002/NAU.21018
P577
2011-01-25T00:00:00Z